{
    "code": "56030512",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56030512",
    "time": "2019-09-06 03:07:35",
    "許可證字號": "衛部醫器輸字第030512號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/02\/27",
    "發證日期": "107\/02\/27",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05603051201",
    "中文品名": "禮雅尚多重腫瘤標記品管物質組",
    "英文品名": "LIAISON Multi-Control Tumour Markers",
    "效能": "本產品是為提供LIAISON及LIAISON XL 自動免疫螢光分析儀分析血清中的腫瘤標記(AFP, CA 125 II, CA 15-3, CA 19-9, CEA, Ferritin, HCG 及β2-Microglobulin)試驗可靠性而設計。",
    "醫器規格": "319109，以下空白。",
    "劑型": "",
    "包裝": "",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "主成分略述": "",
    "主製造廠": {
        "申請商名稱": "620118N044  欣郁儀器股份有限公司",
        "申請商地址": "臺北市中正區忠孝東路一段83號19樓之3",
        "主製造廠": "",
        "製造廠名稱": "MIT0082200  DIASORIN S.P.A.",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "5600305120001-107-04-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030512&Seq=001&Type=9"
        },
        {
            "title": "5600305120002-107-04-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030512&Seq=001&Type=8"
        }
    ]
}